Beth Onners

Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

Dung T. Le, Andrea Wang‐Gillam, Vincent J. Picozzi et al. · Journal of Clinical Oncology · 2015 · 600 citations

Life Sciences, Immunology, Oncology +17

Evaluation of Ipilimumab in Combination With Allogeneic Pancreatic Tumor Cells Transfected With a GM-CSF Gene in Previously Treated Pancreatic Cancer

Dung T. Le, Eric R. Lutz, Jennifer N. Uram et al. · Journal of Immunotherapy · 2013 · 554 citations

Medicine, Oncology, Pharmacology +17

A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma

Lutz Eric, Charles J. Yeo, Keith D. Lillemoe et al. · Annals of Surgery · 2011 · 399 citations · Full text

Medicine, Immunology, Oncology +17

Allogeneic Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation

Dan Laheru, Eric R. Lutz, James M. Burke et al. · Clinical Cancer Research · 2008 · 347 citations · Full text

Medicine, Oncology, Pharmacology +16

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

Takahiro Tsujikawa, Todd S. Crocenzi, Jennifer N. Durham et al. · Clinical Cancer Research · 2020 · 152 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16